Biogen (BIIB) Tops Q4 EPS by 38c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $209.83 -0.39%
Financial Fact:
Income before income tax expense: 1.37B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income before income tax expense: 1.37B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q4 EPS of $1.99, $0.38 better than the analyst estimate of $1.61. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.21 billion.
GUIDANCE:
Biogen sees FY2026 EPS of $15.25-$16.25, versus the consensus of $14.92.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
